{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:00:38Z","timestamp":1792674038022,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,23]],"date-time":"2010-02-23T00:00:00Z","timestamp":1266883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s10875-010-9367-8","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T04:45:10Z","timestamp":1266813910000},"page":"241-252","source":"Crossref","is-referenced-by-count":14,"title":["Inhibition of IFN Regulatory Factor-1 Down-Regulate Th1 Cell Function in Patients with Acute Coronary Syndrome"],"prefix":"10.1007","volume":"30","author":[{"given":"Min","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiutang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,23]]},"reference":[{"key":"9367_CR1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395.","journal-title":"N Engl J Med"},{"key":"9367_CR2","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/01.ATV.0000245830.29764.84","volume":"26","author":"AK Robertson","year":"2006","unstructured":"Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol. 2006;26:2421\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9367_CR3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868\u201374.","journal-title":"Nature"},{"key":"9367_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI111934","volume":"76","author":"L Jonasson","year":"1985","unstructured":"Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK. Expression of class ii transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest. 1985;76:125\u201331.","journal-title":"J Clin Invest"},{"key":"9367_CR5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.ATV.16.8.1013","volume":"16","author":"SE Roselaar","year":"1996","unstructured":"Roselaar SE, Kakkanathu PX, Daugherty A. Lymphocyte populations in atherosclerotic lesions of apoe\u2212\/\u2212 and ldl receptor\u2212\/\u2212 mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol. 1996;16:1013\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9367_CR6","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.jacc.2005.03.040","volume":"45","author":"H Methe","year":"2005","unstructured":"Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER. Enhanced t-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol. 2005;45:1939\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"9367_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","volume":"145","author":"J Frostegard","year":"1999","unstructured":"Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145:33\u201343.","journal-title":"Atherosclerosis"},{"key":"9367_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.CIR.104.2.197","volume":"104","author":"E Laurat","year":"2001","unstructured":"Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariety J, et al. In vivo downregulation of t helper cell 1 immune responses reduces atherogenesis in apolipoprotein e-knockout mice. Circulation. 2001;104:197\u2013202.","journal-title":"Circulation"},{"key":"9367_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MJT.0b013e31816a61bb","volume":"15","author":"M Fisher","year":"2008","unstructured":"Fisher M, Folland E. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences. Am J Ther. 2008;15:137\u201349.","journal-title":"Am J Ther"},{"key":"9367_CR10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10875-005-4088-0","volume":"25","author":"X Cheng","year":"2005","unstructured":"Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J, et al. Th1\/th2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol. 2005;25:246\u201353.","journal-title":"J Clin Immunol"},{"key":"9367_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.arcmed.2009.04.002","volume":"40","author":"QW Ji","year":"2009","unstructured":"Ji QW, Guo M, Zheng JS, Mao XB, Peng YD, Li SN, et al. Downregulation of t helper cell type 3 in patients with acute coronary syndrome. Arch Med Res. 2009;40:285\u201393.","journal-title":"Arch Med Res"},{"key":"9367_CR12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/01.ATV.0000134378.86443.cd","volume":"24","author":"S Potteaux","year":"2004","unstructured":"Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, et al. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:1474\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9367_CR13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.0000018941.10726.FA","volume":"90","author":"LJ Pinderski","year":"2002","unstructured":"Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, et al. Overexpression of interleukin-10 by activated t lymphocytes inhibits atherosclerosis in ldl receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res. 2002;90:1064\u201371.","journal-title":"Circ Res"},{"key":"9367_CR14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cyto.2004.01.007","volume":"26","author":"JL Fernandes","year":"2004","unstructured":"Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, et al. Increased th1 activity in patients with coronary artery disease. Cytokine. 2004;26:131\u20137.","journal-title":"Cytokine"},{"key":"9367_CR15","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.CIR.100.21.2135","volume":"100","author":"G Liuzzo","year":"1999","unstructured":"Liuzzo G, Kopecky SL, Frye RL, O\u2019Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the t-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135\u20139.","journal-title":"Circulation"},{"key":"9367_CR16","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","volume":"24","author":"L Branen","year":"2004","unstructured":"Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:2137\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9367_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1359-6101(00)00032-0","volume":"12","author":"M Sato","year":"2001","unstructured":"Sato M, Taniguchi T, Tanaka N. The interferon system and interferon regulatory factor transcription factors \u2013 studies from gene knockout mice. Cytokine Growth Factor Rev. 2001;12:133\u201342.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9367_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0092-8674(93)90681-F","volume":"75","author":"T Matsuyama","year":"1993","unstructured":"Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, et al. Targeted disruption of irf-1 or irf-2 results in abnormal type i ifn gene induction and aberrant lymphocyte development. Cell. 1993;75:83\u201397.","journal-title":"Cell"},{"key":"9367_CR19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/35636","volume":"391","author":"K Ogasawara","year":"1998","unstructured":"Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, et al. Requirement for irf-1 in the microenvironment supporting development of natural killer cells. Nature. 1998;391:700\u20133.","journal-title":"Nature"},{"key":"9367_CR20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/bj3600285","volume":"360","author":"EM Coccia","year":"2001","unstructured":"Coccia EM, Stellacci E, Valtieri M, Masella B, Feccia T, Marziali G, et al. Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation. Biochem J. 2001;360:285\u201394.","journal-title":"Biochem J"},{"key":"9367_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.185.2.231","volume":"185","author":"Y Tada","year":"1997","unstructured":"Tada Y, Ho A, Matsuyama T, Mak TW. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J Exp Med. 1997;185:231\u20138.","journal-title":"J Exp Med"},{"key":"9367_CR22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/intimm\/dxg086","volume":"15","author":"T Buch","year":"2003","unstructured":"Buch T, Uthoff-Hachenberg C, Waisman A. Protection from autoimmune brain inflammation in mice lacking IFN-regulatory factor-1 is associated with Th2-type cytokines. Int Immunol. 2003;15:855\u20139.","journal-title":"Int Immunol"},{"key":"9367_CR23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/1521-4141(200102)31:2<396::AID-IMMU396>3.0.CO;2-Y","volume":"31","author":"F Sommer","year":"2001","unstructured":"Sommer F, Faller G, Rollinghoff M, Kirchner T, Mak TW, Lohoff M. Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with helicobacter pylori. Eur J Immunol. 2001;31:396\u2013402.","journal-title":"Eur J Immunol"},{"key":"9367_CR24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/jaut.2001.0531","volume":"17","author":"T Nakazawa","year":"2001","unstructured":"Nakazawa T, Satoh J, Takahashi K, Sakata Y, Ikehata F, Takizawa Y, et al. Complete suppression of insulitis and diabetes in nod mice lacking interferon regulatory factor-1. J Autoimmun. 2001;17:119\u201325.","journal-title":"J Autoimmun"},{"key":"9367_CR25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1074-7613(00)80443-4","volume":"6","author":"S Taki","year":"1997","unstructured":"Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 1997;6:673\u20139.","journal-title":"Immunity"},{"key":"9367_CR26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1074-7613(00)80444-6","volume":"6","author":"M Lohoff","year":"1997","unstructured":"Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M, et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 1997;6:681\u20139.","journal-title":"Immunity"},{"key":"9367_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ni0108-9","volume":"9","author":"D Unutmaz","year":"2008","unstructured":"Unutmaz D, Vilcek J. IRF1: a deus ex machina in Th1 differentiation. Nat Immunol. 2008;9:9\u201310.","journal-title":"Nat Immunol"},{"key":"9367_CR28","doi-asserted-by":"crossref","first-page":"28B","DOI":"10.1016\/0002-9149(91)90382-U","volume":"68","author":"E Falk","year":"1991","unstructured":"Falk E. Coronary thrombosis: pathogenesis and clinical manifestations. Am J Cardiol. 1991;68:28B\u201335.","journal-title":"Am J Cardiol"},{"key":"9367_CR29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector t cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123\u201332.","journal-title":"Nat Immunol"},{"key":"9367_CR30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133\u201341.","journal-title":"Nat Immunol"},{"key":"9367_CR31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","volume":"23","author":"C Buono","year":"2003","unstructured":"Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol. 2003;23:454\u201360.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9367_CR32","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","volume":"99","author":"S Gupta","year":"1997","unstructured":"Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in apoe knock-out mice. J Clin Invest. 1997;99:2752\u201361.","journal-title":"J Clin Invest"},{"key":"9367_CR33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/10799900260100141","volume":"22","author":"SC Whitman","year":"2002","unstructured":"Whitman SC, Ravisankar P, Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein e\u2212\/\u2212 mice. J Interferon Cytokine Res. 2002;22:661\u201370.","journal-title":"J Interferon Cytokine Res"},{"key":"9367_CR34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","volume":"157","author":"SC Whitman","year":"2000","unstructured":"Whitman SC, Ravisankar P, Elam H, Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein e\u2212\/\u2212 mice. Am J Pathol. 2000;157:1819\u201324.","journal-title":"Am J Pathol"},{"key":"9367_CR35","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4049\/jimmunol.181.3.1673","volume":"181","author":"A Fragale","year":"2008","unstructured":"Fragale A, Gabriele L, Stellacci E, Borghi P, Perrotti E, Ilari R, et al. IFN regulatory factor-1 negatively regulates cd4+ cd25+ regulatory T cell differentiation by repressing foxp3 expression. J Immunol. 2008;181:1673\u201382.","journal-title":"J Immunol"},{"key":"9367_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/hmg\/ddg018","volume":"12","author":"R Wessely","year":"2003","unstructured":"Wessely R, Hengst L, Jaschke B, Wegener F, Richter T, Lupetti R, et al. A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia. Hum Mol Genet. 2003;12:177\u201387.","journal-title":"Hum Mol Genet."},{"key":"9367_CR37","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.ATV.0000226553.01555.02","volume":"26","author":"P Holvoet","year":"2006","unstructured":"Holvoet P, Davey PC, De Keyzer D, Doukoure M, Deridder E, Bochaton-Piallat ML, et al. Oxidized low-density lipoprotein correlates positively with toll-like receptor 2 and interferon regulatory factor-1 and inversely with superoxide dismutase-1 expression: studies in hypercholesterolemic swine and thp-1 cells. Arterioscler Thromb Vasc Biol. 2006;26:1558\u201365.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9367_CR38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/376596a0","volume":"376","author":"T Tamura","year":"1995","unstructured":"Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, et al. An irf-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated t lymphocytes. Nature. 1995;376:596\u20139.","journal-title":"Nature"},{"key":"9367_CR39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0092-8674(94)90132-5","volume":"77","author":"N Tanaka","year":"1994","unstructured":"Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 1994;77:829\u201339.","journal-title":"Cell"},{"key":"9367_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/107999002753452647","volume":"22","author":"G Romeo","year":"2002","unstructured":"Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, Affabris E. IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res. 2002;22:39\u201347.","journal-title":"J Interferon Cytokine Res"},{"key":"9367_CR41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ni1538","volume":"9","author":"S Kano","year":"2008","unstructured":"Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, Bishop K, et al. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and th1 versus th-17 differentiation of cd4+ T cells. Nat Immunol. 2008;9:34\u201341.","journal-title":"Nat Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-010-9367-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9367-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:10:07Z","timestamp":1559261407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-010-9367-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,23]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9367"],"URL":"https:\/\/doi.org\/10.1007\/s10875-010-9367-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,23]]}}}